BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23962556)

  • 1. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
    Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
    Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
    Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
    J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-144 suppresses tumorigenesis and tumor progression of astrocytoma by targeting EZH2.
    Lin L; Zheng Y; Tu Y; Wang Z; Liu H; Lu X; Xu L; Yuan J
    Hum Pathol; 2015 Jul; 46(7):971-80. PubMed ID: 25907866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.
    Chen DL; Zhang DS; Lu YX; Chen LZ; Zeng ZL; He MM; Wang FH; Li YH; Zhang HZ; Pelicano H; Zhang W; Xu RH
    Oncotarget; 2015 May; 6(13):10868-79. PubMed ID: 25869101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-148 regulates Mitf in melanoma cells.
    Haflidadóttir BS; Bergsteinsdóttir K; Praetorius C; Steingrímsson E
    PLoS One; 2010 Jul; 5(7):e11574. PubMed ID: 20644734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFIB Mediates BRN2 Driven Melanoma Cell Migration and Invasion Through Regulation of EZH2 and MITF.
    Fane ME; Chhabra Y; Hollingsworth DEJ; Simmons JL; Spoerri L; Oh TG; Chauhan J; Chin T; Harris L; Harvey TJ; Muscat GEO; Goding CR; Sturm RA; Haass NK; Boyle GM; Piper M; Smith AG
    EBioMedicine; 2017 Feb; 16():63-75. PubMed ID: 28119061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
    Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
    Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-506 suppresses tumor proliferation and metastasis in colon cancer by directly targeting the oncogene EZH2.
    Zhang Y; Lin C; Liao G; Liu S; Ding J; Tang F; Wang Z; Liang X; Li B; Wei Y; Huang Q; Li X; Tang B
    Oncotarget; 2015 Oct; 6(32):32586-601. PubMed ID: 26452129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis.
    Zhang Q; Zhao W; Ye C; Zhuang J; Chang C; Li Y; Huang X; Shen L; Li Y; Cui Y; Song J; Shen B; Eliaz I; Huang R; Ying H; Guo H; Yan J
    Oncotarget; 2015 Nov; 6(35):37335-48. PubMed ID: 26484567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-625 inhibits tumorigenicity by suppressing proliferation, migration and invasion in malignant melanoma.
    Fang W; Fan Y; Fa Z; Xu J; Yu H; Li P; Gu J
    Oncotarget; 2017 Feb; 8(8):13253-13263. PubMed ID: 28129648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-138 inhibits tumor growth through repression of EZH2 in non-small cell lung cancer.
    Zhang H; Zhang H; Zhao M; Lv Z; Zhang X; Qin X; Wang H; Wang S; Su J; Lv X; Liu H; Du W; Zhou W; Chen X; Fei K
    Cell Physiol Biochem; 2013; 31(1):56-65. PubMed ID: 23343715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-101 inhibits the metastasis of osteosarcoma cells by downregulation of EZH2 expression.
    Zhang K; Zhang Y; Ren K; Zhao G; Yan K; Ma B
    Oncol Rep; 2014 Nov; 32(5):2143-9. PubMed ID: 25190211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-32 Inhibits Proliferation and Metastasis by Targeting EZH2 in Glioma.
    Zhang Y; Wang J; An W; Chen C; Wang W; Zhu C; Chen F; Chen H; Zheng W; Gong J
    Technol Cancer Res Treat; 2019; 18():1533033819854132. PubMed ID: 31138033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MiR-138 Acts as a Tumor Suppressor by Targeting EZH2 and Enhances Cisplatin-Induced Apoptosis in Osteosarcoma Cells.
    Zhu Z; Tang J; Wang J; Duan G; Zhou L; Zhou X
    PLoS One; 2016; 11(3):e0150026. PubMed ID: 27019355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma.
    Huang D; Wang X; Zhuang C; Shi W; Liu M; Tu Q; Zhang D; Hu L
    Oncol Rep; 2016 Feb; 35(2):1083-90. PubMed ID: 26718325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
    Liu F; He Y; Shu R; Wang S
    Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.